| Mouse models for atherosclerosis and pharmaceutical modifiers S Zadelaar, R Kleemann, L Verschuren, J de Vries-Van der Weij, ... Arteriosclerosis, thrombosis, and vascular biology 27 (8), 1706-1721, 2007 | 692 | 2007 |
| Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models R Kleemann, L Verschuren, M Morrison, S Zadelaar, MJ van Erk, ... Atherosclerosis 218 (1), 44-52, 2011 | 452 | 2011 |
| Fibrates down-regulate IL-1–stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFκB–C/EBP-β complex formation R Kleemann, PP Gervois, L Verschuren, B Staels, HMG Princen, ... Blood, The Journal of the American Society of Hematology 101 (2), 545-551, 2003 | 281 | 2003 |
| Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis R Kleemann, L Verschuren, MJ van Erk, Y Nikolsky, NHP Cnubben, ... Genome biology 8, 1-16, 2007 | 279 | 2007 |
| Evidence for anti-inflammatory activity of statins and PPARα activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro R Kleemann, L Verschuren, BJ de Rooij, J Lindeman, MM de Maat, ... Blood 103 (11), 4188-4194, 2004 | 244 | 2004 |
| MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease L Verschuren, T Kooistra, J Bernhagen, PJ Voshol, DM Ouwens, ... Circulation research 105 (1), 99-107, 2009 | 192 | 2009 |
| Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance R Kleemann, M van Erk, L Verschuren, AM van den Hoek, M Koek, ... PloS one 5 (1), e8817, 2010 | 179 | 2010 |
| Proposed guidelines to evaluate scientific validity and evidence for genotype-based dietary advice KA Grimaldi, B van Ommen, JM Ordovas, LD Parnell, JC Mathers, ... Genes & nutrition 12, 1-12, 2017 | 120 | 2017 |
| Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E* 3–Leiden transgenic mice L Verschuren, R Kleemann, EH Offerman, AJ Szalai, SJ Emeis, ... Arteriosclerosis, thrombosis, and vascular biology 25 (1), 161-167, 2005 | 115 | 2005 |
| LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE* 3Leiden mice: time course and mechanismss⃞ L Verschuren, J de Vries-van der Weij, S Zadelaar, R Kleemann, ... Journal of lipid research 50 (2), 301-311, 2009 | 112 | 2009 |
| Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatin K Salic, MC Morrison, L Verschuren, PY Wielinga, L Wu, R Kleemann, ... Atherosclerosis 250, 158-165, 2016 | 107 | 2016 |
| Epicatechin attenuates atherosclerosis and exerts anti-inflammatory effects on diet-induced human-CRP and NFκB in vivo M Morrison, R van der Heijden, P Heeringa, E Kaijzel, L Verschuren, ... Atherosclerosis 233 (1), 149-156, 2014 | 106 | 2014 |
| Butyrate restores HFD-induced adaptations in brain function and metabolism in mid-adult obese mice IAC Arnoldussen, M Wiesmann, CE Pelgrim, EM Wielemaker, ... International journal of obesity 41 (6), 935-944, 2017 | 93 | 2017 |
| Transgenic flavonoid tomato intake reduces C-reactive protein in human C-reactive protein transgenic mice more than wild-type tomato D Rein, E Schijlen, T Kooistra, K Herbers, L Verschuren, R Hall, ... The Journal of nutrition 136 (9), 2331-2337, 2006 | 90 | 2006 |
| Fenofibrate reduces atherogenesis in ApoE* 3Leiden mice: evidence for multiple antiatherogenic effects besides lowering plasma cholesterol T Kooistra, L Verschuren, J de Vries-Van der Weij, W Koenig, K Toet, ... Arteriosclerosis, thrombosis, and vascular biology 26 (10), 2322-2330, 2006 | 85 | 2006 |
| A Dietary Mixture Containing Fish Oil, Resveratrol, Lycopene, Catechins, and Vitamins E and C Reduces Atherosclerosis in Transgenic Mice1–3 L Verschuren, PY Wielinga, W van Duyvenvoorde, S Tijani, K Toet, ... The Journal of nutrition 141 (5), 863-869, 2011 | 66 | 2011 |
| The BCR-ABL1 inhibitors imatinib and ponatinib decrease plasma cholesterol and atherosclerosis, and nilotinib and ponatinib activate coagulation in a translational mouse model MG Pouwer, EJ Pieterman, L Verschuren, MPM Caspers, C Kluft, ... Frontiers in cardiovascular medicine 5, 55, 2018 | 59 | 2018 |
| Mirtoselect, an anthocyanin-rich bilberry extract, attenuates non-alcoholic steatohepatitis and associated fibrosis in ApoE∗ 3Leiden mice MC Morrison, W Liang, P Mulder, L Verschuren, E Pieterman, K Toet, ... Journal of hepatology 62 (5), 1180-1186, 2015 | 59 | 2015 |
| Obeticholic acid modulates serum metabolites and gene signatures characteristic of human NASH and attenuates inflammation and fibrosis progression in Ldlr‐/‐. leiden mice MC Morrison, L Verschuren, K Salic, J Verheij, A Menke, PY Wielinga, ... Hepatology communications 2 (12), 1513-1532, 2018 | 57 | 2018 |
| Up-regulation and coexpression of MIF and matrix metalloproteinases in human abdominal aortic aneurysms L Verschuren, JHN Lindeman, JHV Bockel, H Abdul-Hussien, T Kooistra, ... Antioxidants & Redox Signaling 7 (9-10), 1195-1202, 2005 | 57 | 2005 |
